News

Video

Assessment and Grading of Acute GVHD

Dr Gooptu shares guidance on the assessment and grading of acute GVHD.

Transcript:

Bonnie J. Dirr, APRN: In terms of grading acute graft-vs-host disease [GVHD], can you please talk to us about assessment in the grading scales? And what scales do you use most often?

Mahasweta Gooptu, MD: I alluded to it a little bit with the last question. For acute GVHD, we use the Glucksberg grading system, which is pretty standard and is used by most centers, by which we see, first, then skin. We look at the body surface area involvement. For diarrhea, we look at the volume of diarrhea, and for the liver we look at the degree of hyperbilirubinemia and, for example, for skin, less than 25% is stage 1, 25% to 50% to stage 2. If you have erythroderma, it’s stage 3, and if in addition you have… then that is stage 4. Then similarly you stage each organ and then you put together the numbers for the staging and give the patient a grade. For that we follow the Glucksberg scale. We follow a different method of grading for chronic GVHD, which I think we’ll come to later in the presentation.

Transcript is AI-generated and edited for clarity and readability.

Related Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Farrukh Awan, MD
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Minoo Battiwalla, MD, MS
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss the role of genomic profiling in secondary acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss the treatment goals in secondary acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss factors for picking intensive chemotherapy vs other regimens in acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss dose intensity and sequencing of CPX-351 in secondary acute myeloid leukemia.